Immunotherapy for glioblastoma: quo vadis?

Michael Weller, Emilie Le Rhun,

Nat Rev Clin Oncol

https://doi.org/10.1038/s41571-019-0195-3

Abstract

No abstract available for more information visit: https://doi.org/10.1038/s41571-019-0195-3